Millennium Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,386
| Closed | -$23.1K | – | 6557 |
|
|
2024
Q4 | $23.1K | Buy |
32,386
+6,641
| +26% | +$6.88K | ﹤0.01% | 5698 |
|
|
2024
Q3 | $28.8K | Buy |
25,745
+6,382
| +33% | +$7.14K | ﹤0.01% | 5754 |
|
|
2024
Q2 | $21.1K | Buy |
+19,363
| New | +$21.8K | ﹤0.01% | 5532 |
|
|
2024
Q1 | – | Sell |
-25,309
| Closed | -$35.2K | – | 6750 |
|
|
2023
Q4 | $35.2K | Buy |
+25,309
| New | +$33.6K | ﹤0.01% | 5529 |
|
|
2023
Q2 | – | Sell |
-70,685
| Closed | -$172K | – | 6807 |
|
|
2023
Q1 | $172K | Buy |
+70,685
| New | +$105K | ﹤0.01% | 5235 |
|
|
2021
Q4 | – | Sell |
-39,906
| Closed | -$141K | – | 7489 |
|
|
2021
Q3 | $141K | Sell |
39,906
-374,776
| -90% | -$1.25M | ﹤0.01% | 6276 |
|
|
2021
Q2 | $1.31M | Buy |
414,682
+316,940
| +324% | +$997K | ﹤0.01% | 4411 |
|
|
2021
Q1 | $336K | Buy |
97,742
+51,935
| +113% | +$162K | ﹤0.01% | 5137 |
|
|
2020
Q4 | $115K | Buy |
+45,807
| New | +$99.8K | ﹤0.01% | 4997 |
|
|
2020
Q3 | – | Sell |
-157,855
| Closed | -$354K | – | 4897 |
|
|
2020
Q2 | $354K | Buy |
157,855
+29,935
| +23% | +$77K | ﹤0.01% | 3593 |
|
|
2020
Q1 | $324K | Buy |
127,920
+89,665
| +234% | +$220K | ﹤0.01% | 3136 |
|
|
2019
Q4 | $101K | Buy |
+38,255
| New | +$114K | ﹤0.01% | 4030 |
|
|
2019
Q3 | – | Sell |
-88,466
| Closed | -$298K | – | 4628 |
|
|
2019
Q2 | $298K | Buy |
+88,466
| New | +$312K | ﹤0.01% | 3545 |
|
|
2018
Q4 | – | Sell |
-52,237
| Closed | -$215K | – | 4263 |
|
|
2018
Q3 | $215K | Sell |
52,237
-95,065
| -65% | -$432K | ﹤0.01% | 3613 |
|
|
2018
Q2 | $764K | Sell |
147,302
-378,189
| -72% | -$2.3M | ﹤0.01% | 2974 |
|
|
2018
Q1 | $2.88M | Buy |
525,491
+172,421
| +49% | +$1.21M | ﹤0.01% | 2128 |
|
|
2017
Q4 | $2.88M | Buy |
353,070
+164,871
| +88% | +$1.57M | ﹤0.01% | 2054 |
|
|
2017
Q3 | $1.97M | Buy |
188,199
+130,986
| +229% | +$1.45M | ﹤0.01% | 2175 |
|
|
2017
Q2 | $632K | Buy |
57,213
+30,420
| +114% | +$283K | ﹤0.01% | 2688 |
|
|
2017
Q1 | $224K | Sell |
26,793
-74,829
| -74% | -$527K | ﹤0.01% | 3167 |
|
|
2016
Q4 | $705K | Sell |
101,622
-88,794
| -47% | -$567K | ﹤0.01% | 2461 |
|
|
2016
Q3 | $969K | Sell |
190,416
-3,550
| -2% | -$21.2K | ﹤0.01% | 2290 |
|
|
2016
Q2 | $1.16M | Sell |
193,966
-163,223
| -46% | -$906K | ﹤0.01% | 2074 |
|
|
2016
Q1 | $1.63M | Buy |
357,189
+69,442
| +24% | +$309K | ﹤0.01% | 1908 |
|
|
2015
Q4 | $1.29M | Sell |
287,747
-248,911
| -46% | -$1.05M | ﹤0.01% | 2171 |
|
|
2015
Q3 | $1.7M | Sell |
536,658
-241,026
| -31% | -$731K | ﹤0.01% | 2018 |
|
|
2015
Q2 | $2.36M | Buy |
777,684
+35,874
| +5% | +$101K | ﹤0.01% | 1808 |
|
|
2015
Q1 | $2.19M | Sell |
741,810
-142,205
| -16% | -$466K | ﹤0.01% | 1893 |
|
|
2014
Q4 | $3.92M | Sell |
884,015
-191,605
| -18% | -$914K | 0.01% | 1556 |
|
|
2014
Q3 | $5.54M | Buy |
1,075,620
+49,944
| +5% | +$266K | 0.01% | 1230 |
|
|
2014
Q2 | $5.38M | Buy |
1,025,676
+42,041
| +4% | +$182K | 0.01% | 1172 |
|
|
2014
Q1 | $4.09M | Sell |
983,635
-227,115
| -19% | -$778K | 0.01% | 1311 |
|
|
2013
Q4 | $3.54M | Sell |
1,210,750
-314,250
| -21% | -$779K | 0.01% | 1415 |
|
|
2013
Q3 | $3.84M | Buy |
1,525,000
+15,000
| +1% | +$35.6K | 0.01% | 1268 |
|
|
2013
Q2 | $3.14M | Buy |
+1,510,000
| New | +$3.33M | 0.01% | 1306 |
|
Other funds holding ENZ
HFA
MBAM
WIM
RC
Millennium Management's ENZ Position: Q1 2025 in Review
Millennium Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2025, closing a stake of 32,386 shares — an estimated $23.1K sold.
Millennium Management first reported a position in ENZ in Q2 2013 and held it in 35 quarters. The position peaked at $5.54M in Q3 2014. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2025.
- Millennium Management reported no remaining Enzo Biochem, Inc. position as of Q1 2025 after selling out during the quarter.
- Millennium Management sold 32,386 Enzo Biochem, Inc. shares in Q1 2025, an estimated $23.1K.
- Millennium Management first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 35 quarters.
- Millennium Management's Enzo Biochem, Inc. position peaked at $5.54M in Q3 2014.
- 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2025.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.